IYH logo

iShares U.S. Healthcare ETF (IYH) Análisis de Acciones

Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

iShares U.S. Healthcare ETF (IYH) opera en el sector Financial Services, cotizado por última vez a $ con una capitalización de mercado de 0. Calificado con 46/100 (cauteloso) en potencial de crecimiento, salud financiera e impulso.

Ultimo analisis: 15 mar 2026
Puntuación de IA de 46/100

iShares U.S. Healthcare ETF (IYH) Perfil de Servicios Financieros

Sede CentralSan Francisco, US
Año de la oferta pública inicial (OPI)2000

iShares U.S. Healthcare ETF (IYH) offers investors a focused approach to accessing the U.S. healthcare sector through a diversified portfolio of healthcare equities. With a beta of 0.68, IYH provides relatively lower volatility compared to the broader market, appealing to investors seeking stability within the healthcare industry.

Procedencia de los datos | Datos financieros Análisis cuantitativo NASDAQ Análisis: 15 mar 2026

Tesis de Inversión

The iShares U.S. Healthcare ETF (IYH) presents a targeted investment vehicle for those seeking exposure to the U.S. healthcare sector. With a market capitalization of $2.94 billion, IYH offers diversified access to pharmaceutical, biotechnology, medical device, and healthcare service companies. The ETF's beta of 0.68 suggests lower volatility compared to the broader market. Growth catalysts include ongoing advancements in medical technology and increasing demand for healthcare services due to an aging population. However, potential risks include regulatory changes and pricing pressures within the healthcare industry. Investors may want to evaluate these factors when evaluating IYH's potential for long-term growth.

Basado en las finanzas de FMP y el análisis cuantitativo

Puntos clave

  • Market capitalization of $2.94 billion, indicating a substantial and liquid investment vehicle.
  • Beta of 0.68, suggesting lower volatility compared to the broader market, potentially providing stability during market downturns.
  • Provides targeted exposure to the U.S. healthcare sector, allowing investors to capitalize on the growth potential of this industry.
  • Offers diversification across various healthcare sub-sectors, including pharmaceuticals, medical devices, and healthcare services.
  • Managed by BlackRock, a leading asset manager with extensive experience in ETF management.

Competidores y Pares

Fortalezas

  • Diversified exposure to the U.S. healthcare sector.
  • Low expense ratio compared to actively managed funds.
  • Managed by BlackRock, a leading asset manager.
  • Relatively lower volatility compared to the broader market (beta of 0.68).

Debilidades

  • Sector-specific focus may limit diversification.
  • Performance is highly dependent on the healthcare sector's performance.
  • No dividend yield.
  • Susceptible to regulatory changes and political risks affecting the healthcare industry.

Catalizadores

  • Ongoing: Advancements in medical technology and pharmaceutical innovation driving growth in the healthcare sector.
  • Ongoing: Aging population increasing demand for healthcare services.
  • Upcoming: Potential for new drug approvals and medical breakthroughs.
  • Ongoing: Expansion of healthcare services and access to care.

Riesgos

  • Potential: Regulatory changes and healthcare policy reforms impacting the healthcare industry.
  • Potential: Pricing pressures and cost containment measures affecting healthcare companies.
  • Potential: Economic downturns impacting healthcare spending.
  • Ongoing: Competition from other healthcare ETFs and investment vehicles.
  • Potential: Patent expirations and generic drug competition.

Oportunidades de crecimiento

  • Demographic Shifts: The aging population in the United States is driving increased demand for healthcare services, creating a long-term growth opportunity for IYH. As the number of older adults grows, so does the need for medical treatments, pharmaceuticals, and healthcare technologies. This demographic trend is expected to continue for the next several decades, providing a sustained tailwind for the healthcare sector and, consequently, for IYH. The market size for geriatric care alone is projected to reach hundreds of billions of dollars by 2030.
  • Technological Advancements: Ongoing advancements in medical technology, such as minimally invasive surgery, personalized medicine, and digital health solutions, are transforming the healthcare landscape. These innovations are creating new opportunities for companies within the healthcare sector to develop and market cutting-edge products and services. IYH, with its diversified portfolio of healthcare stocks, is well-positioned to benefit from these technological advancements. The global market for digital health is expected to reach $660 billion by 2025.
  • Pharmaceutical Innovation: The pharmaceutical industry is constantly developing new drugs and therapies to treat a wide range of diseases. Breakthroughs in areas such as oncology, immunology, and gene therapy are driving significant growth in the pharmaceutical market. IYH's exposure to pharmaceutical companies allows investors to participate in the potential upside from these innovations. The global pharmaceutical market is projected to reach $1.5 trillion by 2023.
  • Healthcare Services Expansion: The healthcare services sector is expanding as healthcare providers seek to improve access to care, enhance patient outcomes, and reduce costs. The growth of telehealth, home healthcare, and outpatient services is creating new opportunities for companies in this sector. IYH's holdings in healthcare service providers allow investors to benefit from this expansion. The telehealth market, for example, is expected to reach $55 billion by 2025.
  • Increased Healthcare Spending: Overall healthcare spending is projected to increase in the coming years, driven by factors such as rising healthcare costs, an aging population, and increased access to healthcare services. This trend is expected to benefit companies across the healthcare sector, including those held by IYH. The Centers for Medicare & Medicaid Services (CMS) projects that U.S. healthcare spending will grow at an average rate of 5.4% per year from 2019 to 2028.

Oportunidades

  • Aging population driving increased demand for healthcare services.
  • Technological advancements and innovation in the healthcare sector.
  • Potential for growth in emerging markets with increasing healthcare needs.
  • Increasing healthcare spending as a percentage of GDP.

Amenazas

  • Regulatory changes and healthcare policy reforms.
  • Pricing pressures and cost containment measures in the healthcare industry.
  • Competition from other healthcare ETFs and mutual funds.
  • Economic downturns impacting healthcare spending.

Ventajas competitivas

  • Established brand and reputation of iShares and BlackRock.
  • Diversified portfolio of healthcare stocks.
  • Low expense ratio compared to actively managed healthcare funds.

Acerca de IYH

The iShares U.S. Healthcare ETF (IYH) is designed to provide investors with exposure to U.S. companies operating within the healthcare sector. Managed by BlackRock, one of the world's largest asset managers, IYH seeks to track the investment results of an index composed of U.S. equities in the healthcare sector. The ETF includes companies involved in pharmaceuticals, medical devices, healthcare services, and biotechnology. By investing in IYH, investors gain access to a diversified portfolio of healthcare stocks, potentially benefiting from the sector's growth and innovation. The ETF's holdings reflect the composition of the underlying index, which is rebalanced periodically to maintain its intended sector exposure. IYH offers a convenient and cost-effective way for investors to participate in the U.S. healthcare market, without the need to individually select and manage a portfolio of healthcare stocks. The ETF's performance is closely tied to the overall health and growth of the U.S. healthcare industry, making it a valuable tool for investors seeking to allocate capital to this sector.

Qué hacen

  • Tracks the investment results of an index composed of U.S. equities in the healthcare sector.
  • Provides investors with exposure to a diversified portfolio of healthcare stocks.
  • Includes companies involved in pharmaceuticals, medical devices, healthcare services, and biotechnology.
  • Offers a convenient and cost-effective way to invest in the U.S. healthcare market.
  • Rebalances its holdings periodically to maintain its intended sector exposure.
  • Allows investors to participate in the growth and innovation of the healthcare industry.
  • Aims to replicate the performance of its underlying index.

Modelo de Negocio

  • Tracks a specific index of U.S. healthcare companies.
  • Generates revenue through management fees charged to investors.
  • Provides a diversified investment vehicle for accessing the healthcare sector.

Contexto de la Industria

The iShares U.S. Healthcare ETF (IYH) operates within the asset management industry, focusing specifically on providing investors with exposure to the U.S. healthcare sector. The healthcare industry is experiencing growth driven by an aging population, technological advancements, and increasing demand for medical services. The competitive landscape includes other healthcare ETFs and mutual funds, each with varying investment strategies and expense ratios. IYH's market position is strengthened by its affiliation with BlackRock, a well-established asset manager with a strong track record.

Clientes Clave

  • Individual investors seeking exposure to the healthcare sector.
  • Institutional investors looking for a diversified healthcare investment.
  • Financial advisors seeking to allocate client assets to the healthcare market.
Confianza de la IA: 73% Actualizado: 15 mar 2026

Finanzas

Gráfico e información

Precio de la acción de iShares U.S. Healthcare ETF (IYH): Price data unavailable

Últimas noticias

Consenso de analistas

Calificación de Consenso

Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para IYH.

Objetivos de Precios

Análisis del precio objetivo de Wall Street para IYH.

MoonshotScore

46/100

¿Qué significa esta puntuación?

El MoonshotScore califica el potencial de crecimiento de IYH en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.

IYH Preguntas Frecuentes sobre Acciones de Financial Services

¿Cuáles son los factores clave para evaluar IYH?

iShares U.S. Healthcare ETF (IYH) actualmente tiene una puntuación IA de 46/100, indicando puntuación baja. Fortaleza clave: Diversified exposure to the U.S. healthcare sector.. Riesgo principal a monitorear: Potential: Regulatory changes and healthcare policy reforms impacting the healthcare industry.. Esto no es asesoramiento financiero.

¿Qué es el MoonshotScore de IYH?

IYH actualmente puntúa 46/100 (Grado D) en el MoonshotScore, lo que sugiere calificación baja. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.

¿Con qué frecuencia se actualizan los datos de IYH?

Los precios de IYH se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.

¿Qué dicen los analistas sobre IYH?

La cobertura de analistas para IYH incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.

¿Cuáles son los riesgos de invertir en IYH?

Las categorías de riesgo para IYH incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Regulatory changes and healthcare policy reforms impacting the healthcare industry.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.

¿Cuál es la relación P/E de IYH?

La relación P/E para IYH compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.

¿Está IYH sobrevalorada o infravalorada?

Determinar si iShares U.S. Healthcare ETF (IYH) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.

¿Cuál es el rendimiento por dividendo de IYH?

iShares U.S. Healthcare ETF (IYH) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.

Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.

Recursos Oficiales

Análisis actualizado el Puntuación de IA actualizada diariamente
Fuentes de Datos y Metodología
Datos de mercado proporcionados por Financial Modeling Prep y Yahoo Finance. Análisis de IA por algoritmos propietarios de Stock Expert AI. Indicadores técnicos mediante cálculos estándar de la industria. Última actualización: .

Datos proporcionados solo con fines informativos.

Notas de análisis
  • AI analysis pending for IYH. Financial data is based on available information as of 2026-03-15.
Fuentes de datos

Popular Stocks